182 related articles for article (PubMed ID: 18321241)
21. The Endogenous Dual Retinoid Receptor Agonist Alitretinoin Exhibits Immunoregulatory Functions on Antigen-Presenting Cells.
Kislat A; Olah P; Kuchner M; Gerber PA; Schrader J; Meller S; Homey B
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298605
[TBL] [Abstract][Full Text] [Related]
22. Oral alitretinoin treatment in patients with palmoplantar pustulosis inadequately responding to standard topical treatment: a randomized phase II study.
Reich K; Graff O; Mehta N
Br J Dermatol; 2016 Jun; 174(6):1277-81. PubMed ID: 26800106
[TBL] [Abstract][Full Text] [Related]
23. Alitretinoin: in severe chronic hand eczema.
Garnock-Jones KP; Perry CM
Drugs; 2009 Aug; 69(12):1625-34. PubMed ID: 19678713
[TBL] [Abstract][Full Text] [Related]
24. Nail improvement during alitretinoin treatment: three case reports and review of the literature.
Milanesi N; D'Erme AM; Gola M
Clin Exp Dermatol; 2015 Jul; 40(5):533-6. PubMed ID: 25682921
[TBL] [Abstract][Full Text] [Related]
25. A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of alitretinoin (BAL4079) in the treatment of severe chronic hand eczema refractory to potent topical corticosteroid therapy.
Fowler JF; Graff O; Hamedani AG
J Drugs Dermatol; 2014 Oct; 13(10):1198-204. PubMed ID: 25607554
[TBL] [Abstract][Full Text] [Related]
26. Phase III vehicle-controlled, multi-centered study of topical alitretinoin gel 0.1% in cutaneous AIDS-related Kaposi's sarcoma.
Bodsworth NJ; Bloch M; Bower M; Donnell D; Yocum R;
Am J Clin Dermatol; 2001; 2(2):77-87. PubMed ID: 11705307
[TBL] [Abstract][Full Text] [Related]
27. [Kaposi's sarcoma treated with topical alitretinoin].
González de Arriba A; Pérez-Gala S; Goiriz-Valdés R; Ríos-Buceta L; García-Díez A
Actas Dermosifiliogr; 2007; 98(1):50-3. PubMed ID: 17374335
[TBL] [Abstract][Full Text] [Related]
28. Oral alitretinoin. Severe chronic hand eczema: this retinoid is too risky.
Prescrire Int; 2010 Apr; 19(106):62-3. PubMed ID: 20568484
[No Abstract] [Full Text] [Related]
29. Safety of alitretinoin for severe refractory chronic hand eczema: Clinical studies and postmarketing surveillance.
Morris M; Schifano L; Fong R; Graff O
J Dermatolog Treat; 2016; 27(1):54-8. PubMed ID: 25886084
[TBL] [Abstract][Full Text] [Related]
30. Alitretinoin: A Review in Severe Chronic Hand Eczema.
Blair HA; Scott LJ
Drugs; 2016 Sep; 76(13):1271-1279. PubMed ID: 27438290
[TBL] [Abstract][Full Text] [Related]
31. Oral alitretinoin in chronic refractory hand eczema: a "real life" case-series of 12 patients.
Kubica E; Ezzedine K; Lalanne N; Dartial Y; Taieb A; Milpied B
Eur J Dermatol; 2011; 21(3):454-6. PubMed ID: 21680291
[No Abstract] [Full Text] [Related]
32. The expression of retinoic acid receptors and the effects in vitro by retinoids in human pancreatic cancer cell lines.
Albrechtsson E; Ohlsson B; Axelson J
Pancreas; 2002 Jul; 25(1):49-56. PubMed ID: 12131771
[TBL] [Abstract][Full Text] [Related]
33. Oral 9-cis retinoic acid (Alitretinoin) in the treatment of myelodysplastic syndromes: results from a pilot study.
Hofmann WK; Kell WJ; Fenaux P; Castaigne S; Ganser A; Chomienne C; Burnett R; Kowal C; Hoelzer D; Burnett AK
Leukemia; 2000 Sep; 14(9):1583-8. PubMed ID: 10995004
[TBL] [Abstract][Full Text] [Related]
34. [Alitretinoin in chronic hand eczema: summary of clinical trials].
Richard MA
Ann Dermatol Venereol; 2010 Nov; 137 Suppl 3():S111-23. PubMed ID: 21185982
[TBL] [Abstract][Full Text] [Related]
35. Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema.
Bissonnette R; Worm M; Gerlach B; Guenther L; Cambazard F; Ruzicka T; Maares J; Brown TC
Br J Dermatol; 2010 Feb; 162(2):420-6. PubMed ID: 19906075
[TBL] [Abstract][Full Text] [Related]
36. Impact of systemic alitretinoin treatment on skin barrier gene and protein expression in patients with chronic hand eczema.
Kumari V; Timm K; Kühl AA; Heine G; Worm M
Br J Dermatol; 2016 Dec; 175(6):1243-1250. PubMed ID: 27480504
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial.
Ruzicka T; Lynde CW; Jemec GB; Diepgen T; Berth-Jones J; Coenraads PJ; Kaszuba A; Bissonnette R; Varjonen E; Holló P; Cambazard F; Lahfa M; Elsner P; Nyberg F; Svensson A; Brown TC; Harsch M; Maares J
Br J Dermatol; 2008 Apr; 158(4):808-17. PubMed ID: 18294310
[TBL] [Abstract][Full Text] [Related]
38. Failure of topical 0.1% alitretinoin gel for classic Kaposi sarcoma: first European experience.
Rongioletti F; Zaccaria E; Viglizzo G
Br J Dermatol; 2006 Oct; 155(4):856-7. PubMed ID: 16965450
[No Abstract] [Full Text] [Related]
39. Successful treatment of chronic hand eczema with oral 9-cis-retinoic acid.
Bollag W; Ott F
Dermatology; 1999; 199(4):308-12. PubMed ID: 10640839
[TBL] [Abstract][Full Text] [Related]
40. Treatment of cutaneous T-cell lymphoma with alitretinoin gel.
Bassiri-Tehrani S; BA BA; Cohen DE
Int J Dermatol; 2002 Feb; 41(2):104-6. PubMed ID: 11982647
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
